ESPOSITO, Emanuela
 Distribuzione geografica
Continente #
EU - Europa 19.106
NA - Nord America 16.372
AS - Asia 11.412
SA - Sud America 3.454
AF - Africa 309
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 11
Totale 50.689
Nazione #
US - Stati Uniti d'America 15.898
RU - Federazione Russa 10.134
SG - Singapore 4.951
CN - Cina 3.091
BR - Brasile 2.942
IE - Irlanda 2.199
SE - Svezia 1.814
IT - Italia 1.591
HK - Hong Kong 1.162
DE - Germania 684
VN - Vietnam 621
FR - Francia 500
GB - Regno Unito 441
PL - Polonia 422
UA - Ucraina 418
FI - Finlandia 348
IN - India 327
BD - Bangladesh 265
CA - Canada 244
AR - Argentina 180
MX - Messico 149
TR - Turchia 137
NL - Olanda 129
AT - Austria 113
JP - Giappone 104
ZA - Sudafrica 102
ID - Indonesia 98
IQ - Iraq 96
EC - Ecuador 86
BE - Belgio 84
PK - Pakistan 81
UZ - Uzbekistan 72
MA - Marocco 66
VE - Venezuela 66
ES - Italia 62
CO - Colombia 60
CL - Cile 37
AE - Emirati Arabi Uniti 36
MY - Malesia 36
IR - Iran 35
JO - Giordania 32
PY - Paraguay 31
SA - Arabia Saudita 30
TN - Tunisia 28
CZ - Repubblica Ceca 26
LT - Lituania 25
PH - Filippine 24
NP - Nepal 22
KE - Kenya 21
PE - Perù 21
AZ - Azerbaigian 20
DZ - Algeria 20
AU - Australia 19
KG - Kirghizistan 19
EG - Egitto 18
IL - Israele 18
OM - Oman 17
UY - Uruguay 17
PS - Palestinian Territory 16
TH - Thailandia 14
TW - Taiwan 14
DO - Repubblica Dominicana 13
BO - Bolivia 12
HU - Ungheria 12
PA - Panama 12
CI - Costa d'Avorio 11
JM - Giamaica 11
KR - Corea 11
CH - Svizzera 10
CR - Costa Rica 10
KZ - Kazakistan 10
LB - Libano 10
HN - Honduras 9
NO - Norvegia 9
AL - Albania 8
AO - Angola 8
GE - Georgia 8
RS - Serbia 8
BG - Bulgaria 7
BY - Bielorussia 7
EE - Estonia 7
GT - Guatemala 7
RO - Romania 7
SV - El Salvador 7
ET - Etiopia 6
PT - Portogallo 6
DK - Danimarca 5
EU - Europa 5
GR - Grecia 5
LA - Repubblica Popolare Democratica del Laos 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
CG - Congo 4
LK - Sri Lanka 4
LV - Lettonia 4
MD - Moldavia 4
NI - Nicaragua 4
QA - Qatar 4
Totale 50.622
Città #
Moscow 2.966
Ashburn 2.958
Singapore 2.450
Dublin 2.198
Dallas 1.671
Chandler 1.614
Nyköping 1.215
Hong Kong 1.153
Beijing 930
Jacksonville 828
San Jose 784
The Dalles 529
Messina 444
Princeton 404
Warsaw 399
Los Angeles 390
Dearborn 348
Lauterbourg 333
New York 316
Medford 313
Des Moines 264
Boardman 260
Cambridge 251
Munich 237
São Paulo 236
Ann Arbor 232
Buffalo 190
Ho Chi Minh City 186
Tianjin 153
Guangzhou 135
Lancaster 129
Hanoi 126
Council Bluffs 125
Redondo Beach 121
Santa Clara 113
Orem 106
Rio de Janeiro 105
Shenyang 101
Houston 100
Jinan 100
Rome 97
Tokyo 89
Wilmington 88
Brussels 81
Vienna 79
Montreal 78
Frankfurt am Main 73
Nanjing 73
Catania 72
Milan 71
Belo Horizonte 67
Chennai 66
Pune 64
San Mateo 64
Tashkent 62
Woodbridge 61
Ottawa 60
Brooklyn 59
Shanghai 58
London 56
Atlanta 55
Cologne 53
Turku 53
Johannesburg 52
Chicago 51
Hyderabad 50
Shenzhen 50
Mexico City 49
Baghdad 48
Dong Ket 48
Hebei 48
Jakarta 48
Zhengzhou 47
Ningbo 46
Denver 45
Curitiba 44
San Francisco 44
Amsterdam 43
Seattle 43
Haikou 42
Stockholm 42
Brasília 40
Düsseldorf 39
Palermo 37
Phoenix 37
Boston 36
Campinas 36
Guayaquil 35
Manchester 35
Poplar 35
Helsinki 34
Nuremberg 34
Porto Alegre 34
Istanbul 33
Nanchang 33
Salvador 33
Hangzhou 31
Toronto 31
Ankara 30
Falls Church 30
Totale 28.585
Nome #
Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. 255
2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation 249
Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. 243
Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein 238
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 234
Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 229
The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats 228
PPAR-α Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury 227
A Systematic Review and Meta-Analysis of the Association between the FV H1299R Variant and the Risk of Recurrent Pregnancy Loss 225
Celenterati Cnidari come modello per lo studio di tossicità da metalli pesanti. 219
Influence of coagulase-negative staphylococci as potential probiotics on Dry Eye 218
3,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease 217
Absence of endogenous Interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. 213
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury 211
B Cell depletion with CD20 antibodies as new approach in the treatment of inflammatory and immunological events associated with spinal cord 207
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome 207
Dimethyl fumarate reduces inflammatory responses in experimental colitis 206
Effects of Physical Exercise and Motor Activity on Oxidative Stress and Inflammation in Post Mastectomy Pain Syndrome 205
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation 204
Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies 203
Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-alpha 202
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation 201
Beneficial effect of tempol, a membrane-permeable radical scavenger, on inflammation and osteoarthritis in in vitro models 201
Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury. 198
BAY-117082-driven NLRP3 inflammasome inhibition resolves nitro-glycerine (NTG) neuronal damage in in vivo model of migraine 196
Correction to: Potential eye drop based on a calix[4]arene nanoassembly for curcumin delivery: Enhanced drug solubility, stability, and anti-inflammatory effect (Molecular Pharmaceutics (2017) 14:5 (1610-1622) DOI: 10.1021/acs.molpharmaceut.6b01066) 194
Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury 193
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma 192
Anti-inflammatory and Antioxidant Effects of Flavonoid-Rich Fraction of Bergamot Juice (BJe) in a Mouse Model of Intestinal Ischemia/Reperfusion Injury 191
Protein Hydrolysates from Anchovy (Engraulis encrasicolus) Waste: In Vitro and In Vivo Biological Activities 191
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 190
Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice. 188
Antioxidant and anti-inflammatory effect of nrf2 inducer dimethyl fumarate in neurodegenerative diseases 188
A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy 185
Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury 184
B Cell-Targeted Therapy with Anti-CD20 Monoclonal Antibody Reduced Secondary Tissue Damage and Enhanced Behavioural Recovery Following Experimental Spinal Cord Injury in Mice 183
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice 183
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis 183
A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock 181
Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury 181
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism 181
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury 180
Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study 176
Ethyl-piruvate reduces the developments of zymosine-induced generalized inflammatory in mice 174
Adenosine A2A receptor selective stimulation reduces mitogen activated protein kinases in spinal cord injury: activation of jnk is reduced in oligodendrocytes 174
A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury. 174
Carbon dots as promising tools for cancer diagnosis and therapy 174
Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain 173
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 172
Absence of peroxisome proliferators activated receptors alpha (PPAR-) enhanced the multiple organ failure induced by zymosan. 171
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion 171
Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice 169
H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol 168
A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo 168
Role of melatonin supplementation in neurodegenerative disorders. 167
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2 166
Aspetti tossicologici di estratto crudo da Pelagia noctiluca (Cnidaria: Scyphozoa). 165
Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents 164
Adenosine A2a receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma (Biological Regulators and Homeostatical Agents (73)) 163
A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome 162
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury 162
N-palmitoylethanolamine administration ameliorates the clinical manifestation and progression of experimental autoimmune encephalomyelitis in rodents 162
TAK1 inhibitor enhances the therapeutic treatment for glioblastoma 162
Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury 162
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-alpha MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE. 161
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 160
The protective role of prolyl oligopeptidase (pop) inhibition in acute lung injury induced by intestinal ischemia-reperfusion 160
Effects of Physical Exercise and Motor Activity on Depression and Anxiety in Post-Mastectomy Pain Syndrome 159
Dimethyl Fumarate (DMF) Alleviated Post-Operative (PO) Pain through the N-Methyl-d-Aspartate (NMDA) Receptors 156
Glycogen synthase kinase 3 beta inhibition reduces the development of nonseptic shock induced by zymosan in mice 156
Effect of co-ultramicronized palmitoylethanolamide and luteolin association on neurogenesis in a mouse model of spinal cord injury 156
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α. 155
A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways. 155
BENEFICIAL EFFECTS OF ETHYL PYRUVATE IN A MOUSE MODEL OF SPINAL CORD INJURY. 154
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia 154
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury 154
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness 153
The neuroprotective effects of co-ultraPEALut in a mouse model of spinal cord injury 153
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency 153
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model 153
Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance 152
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 150
Role of Dkk-3 in the neoplastic progression of meningiomas. Could it represent a new therapeutic target? 150
Au, Pd and maghemite nanofunctionalized hydroxyapatite scaffolds for bone regeneration 149
Autophagy and Liver Diseases 148
Potential Therapeutic Effects of PPAR Ligands in Glioblastoma 146
Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury 144
Inhibition of Poly(ADP-Ribose) Polymerase Activity Modulates Autophagy Induced by Experimental Spinal Cord Trauma 144
A controlled cortical impact preclinical model of traumatic brain injury 144
Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis. 143
PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice 143
Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury 142
P12.05 Role of Dkk-3 in the neoplastic progression of meningiomas. Could it represent a new therapeutic target? 142
Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis 141
Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept 141
Palmitoylethanolamide ameliorates development of colitis caused by injection of dinitrobenzene sulfonic acid (DNBS) in mice 141
GREEN TEA POLYPHENOL EXTRACT ATTENUATES ZYMOSAN-INDUCED NON SEPTICK SHOCK IN MICE 141
GW0742, a high-affinity PPAR -beta/delta agonist, inhibits acute lung injury in mice 140
Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis 140
An in vivo compression model of spinal cord injury 140
Totale 17.676
Categoria #
all - tutte 179.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 179.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021124 0 0 0 0 0 0 0 0 0 0 0 124
2021/20222.328 23 173 55 92 117 36 181 91 75 132 470 883
2022/20236.430 533 524 288 528 465 644 95 356 2.705 46 178 68
2023/20241.836 128 271 108 156 157 404 81 101 23 99 35 273
2024/20258.657 164 89 250 404 410 248 278 1.590 2.137 505 1.046 1.536
2025/202626.531 1.342 1.594 2.020 1.962 2.130 5.445 3.168 3.073 3.241 1.340 577 639
Totale 51.556